Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Injectable contraceptives industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Age group trends
2.1.5 Duration of action trends
2.1.6 End-user trends
Chapter 3 Injectable Contraceptives Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in awareness about family planning
3.2.1.2 Increasing awareness about benefits of injectable contraceptives
3.2.1.3 Initiatives by government and other organizations to increase access to injectable contraceptives
3.2.2 Industry pitfalls & challenges
3.2.2.1 After effects associated with injectable contraceptives
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By age group
3.3.3 By duration of action
3.3.4 By end-user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Injectable Contraceptives Market, By Type, 2018 - 2032 (USD Million)
5.1 Key trends, by type
5.2 Progesterone-only injectables
5.2.1 Depot medroxyprogesterone acetate
5.2.2 Norethisterone enanthate
5.3 Combined injectable contraceptives
Chapter 6 Injectable Contraceptives Market, By Age Group, 2018 – 2032 (USD Million)
6.1 Key trends, by age group
6.2 15–24 years
6.3 25–34 years
6.4 35–44 years
6.5 Above 44 years
Chapter 7 Injectable Contraceptives Market, By Duration of Action, 2018 - 2032 (USD Million)
7.1 Key trends, by duration of action
7.2 Short-acting injectable contraceptives
7.3 Long-acting injectable contraceptives
Chapter 8 Injectable Contraceptives Market, By End-user, 2018 - 2032 (USD Million)
8.1 Key trends, by end-user
8.2 Hospital
8.3 Gynecology clinics
8.4 Other end-users
Chapter 9 Injectable Contraceptives Market, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Pfizer Inc.
10.2 Amphastar Pharmaceutical Inc.
10.3 Zhejiang Xianju Pharmaceutical Co., Ltd
10.4 Eugia Pharma
10.5 Mylan Labs Ltd
10.6 Bayer Plc
10.7 Teva Pharms USA
10.8 PT Tunggal
10.9 Incepta Pharmaceuticals
10.10 Baxter International Inc.
